Memantine Hydrochloride
Average across 36 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | generic | 12 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | generic | 12 | SUPPLYING |
| Zydus Lifesciences Limited | generic | 12 | SUPPLYING |
| Aurobindo Pharma Limited | generic | 8 | SUPPLYING |
| Macleods Pharmaceuticals Limited | generic | 8 | SUPPLYING |
| Slate Run Pharmaceuticals, LLC | unknown | 6 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | generic | 6 | SUPPLYING |
| Vitruvias Therapeutics | unknown | 4 | SUPPLYING |
| Major Pharmaceuticals | relabeler | 2 | SUPPLYING |
| NCS HealthCare of KY, LLC dba Vangard Labs | repackager | 1 | EXITED 2026 |
Shortages, recalls, and registration changes attached to this drug concept.
Failed Dissolution Specifications — Recalling firm: The Harvard Drug Group LLC — US Nationwide.
Failed dissolution specifications: Low stage 3 results obtained for dissolution during routine stability testing. — Recalling firm: The Harvard Drug Group — AL, FL, IA, NY, OH, TX
Failed Dissolution Specifications: Low out of specification results observed in dissolution test at six-month long-term stability study. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide within the United States.
Failed Dissolution Specifications: High out of specification result observed at stability studies. — Recalling firm: The Harvard Drug Group — U.S.A. Nationwide
Failed Dissolution Specifications: High out of specification result observed at stability studies. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide in the USA
